representative work

Cassels Acts for DionyMed Brands in Connection with up to US$40 Million Credit Facility


On January 16, 2019, DionyMed Brands Inc. signed a definitive agreement for a two year, up to US$40 million senior secured credit facility from a syndicate of investors. The credit facility consists of a US$15 million term loan facility and a US$25 million asset-backed loan facility. DionyMed will draw US$13 million following the completion of certain conditions to the satisfaction of the investors.

Cassels acted for DionyMed Brands.

RELATED EXPERTISE: Cannabis | Securities